Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panobinostat and Everolimus in Relapsed Multiple Myeloma or Lymphoma
NCT00918333Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Jun 2009
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of panobinostat, everolimus in multiple myeloma (MM), non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), sponsored by Mayo Clinic. Started Jun 2009; status: completed.
02
Drugs
panobinostateverolimus
03
Conditions
multiple myeloma (MM)non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00918333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00918333.